Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Express Scripts
Baxter
Colorcon

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021524

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 021524 describes PREVANTICS SWABSTICK, which is a drug marketed by Prof Dspls and is included in one NDA. It is available from one supplier. Additional details are available on the PREVANTICS SWABSTICK profile page.

The generic ingredient in PREVANTICS SWABSTICK is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
Summary for 021524
Suppliers and Packaging for NDA: 021524
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREVANTICS MAXI SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021524 NDA Professional Disposables International, Inc. 10819-1080 10819-1080-2 3000 POUCH in 1 CASE (10819-1080-2) > 1 mL in 1 POUCH
PREVANTICS MAXI SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021524 NDA Professional Disposables International, Inc. 10819-1080 10819-1080-1 100 POUCH in 1 BOX (10819-1080-1) > 1 mL in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SWAB;TOPICALStrength3.15%;70% (1ML)
Approval Date:Jun 3, 2005TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 14, 2021
Regulatory Exclusivity Use:DRUG FACTS LABELING CHANGES UNDER THE DIRECTIONS HEADING TO REVISE THE STATED PREPARATION TIME OF A DRY SITE FROM 120 SECONDS SCRUBBING AND 90 SECONDS DRYING TO 30 SECONDS SCRUBBING AND 30 SECONDS DRYING

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SWAB;TOPICALStrength3.15%;70% (1.6ML)
Approval Date:Jun 3, 2005TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 14, 2021
Regulatory Exclusivity Use:DRUG FACTS LABELING CHANGES UNDER THE DIRECTIONS HEADING TO REVISE THE STATED PREPARATION TIME OF A DRY SITE FROM 120 SECONDS SCRUBBING AND 90 SECONDS DRYING TO 30 SECONDS SCRUBBING AND 30 SECONDS DRYING

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:SWAB;TOPICALStrength3.15%;70% (5.1ML)
Approval Date:Jun 3, 2005TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 14, 2021
Regulatory Exclusivity Use:DRUG FACTS LABELING CHANGES UNDER THE DIRECTIONS HEADING TO REVISE THE STATED PREPARATION TIME OF A DRY SITE FROM 120 SECONDS SCRUBBING AND 90 SECONDS DRYING TO 30 SECONDS SCRUBBING AND 30 SECONDS DRYING

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Medtronic
McKesson
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.